#DollarHits3MonthLow
$SOXL Perp $KORU Perp
Swiss Drug maker Sandoz has decided to pay upto 77 million USD to Shanghai Helinus Biotech to develop Cholesterol, Colorectal Cancer& lupus molecule.
Jhonson & Jhonson is in a deal to lead Delix Theraoeutics worth 85 million USD for non hallucinogenic Psychedeluc drug.
Dollar Index --- Stagnation --- Smooth Capital Bridging us Expected ---- DowJones ---- Varible Slope --- Downward
$SOXL Perp $KORU Perp
Swiss Drug maker Sandoz has decided to pay upto 77 million USD to Shanghai Helinus Biotech to develop Cholesterol, Colorectal Cancer& lupus molecule.
Jhonson & Jhonson is in a deal to lead Delix Theraoeutics worth 85 million USD for non hallucinogenic Psychedeluc drug.
Dollar Index --- Stagnation --- Smooth Capital Bridging us Expected ---- DowJones ---- Varible Slope --- Downward